TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
doi 10.1055/s-0038-1675457
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Georg Thieme Verlag KG